C3 and systemic lupus erythematosus: Clinically, unrestricted complement consumption manifests as low serum C3 and C4 levels, a classic indicator of SLE activity, that is incorporated into disease activity indices like the SLEDAI (SLE disease activity index) score (Bombardier et al, 1992).